• SalvaRx Group

    The SalvaRx Group is a drug development company focused on cancer immunotherapy
  • Cancer Immunotherapy

    Cancer immunotherapy—treatments that harness and enhance the innate powers of the immune system to fight cancer—is one of the most promising cancer treatment modalities since the development of targeted therapies.

About SalvaRx Group

The SalvaRx Group is a drug development company focused on cancer immunotherapy and complementary areas of oncology. Following a group restructuring in March 2017, all the Company’s investments and business interests were held by its subsidiary SalvaRx Limited.

Read more